Omzet 2024 * | 2,72 mld. 10,19 mld. 2,54 mld. | Omzet 2025 * | 3,05 mld. 11,42 mld. 2,85 mld. | Marktkapitalisatie | 14 mld. 52,39 mld. 13,08 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 439 mln. 1,64 mld. 410 mln. | Nettowinst (verlies) 2025 * | 528 mln. 1,98 mld. 493 mln. | EV/omzet 2024 * | 4,66 x |
Nettoliquiditeiten 2024 * | 1,32 mld. 4,93 mld. 1,23 mld. | Nettoliquiditeiten 2025 * | 2,15 mld. 8,05 mld. 2,01 mld. | EV/omzet 2025 * | 3,88 x |
K/w-verhouding 2024 * |
33,9
x | K/w-verhouding 2025 * |
27,9
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 84,08% |
Recentste transcriptie over NICE Ltd.
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Barak Eilam
CEO | Chief Executive Officer | 49 | 30-04-14 |
Darren Rushworth
PSD | President | 56 | 01-01-17 |
Mary Gaspich
DFI | Director of Finance/CFO | 59 | 01-10-16 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Léo Apotheker
BRD | Director/Board Member | 69 | 01-08-13 |
David Kostman
CHM | Chairman | 59 | 01-01-01 |
Dan Falk
BRD | Director/Board Member | 79 | 01-01-01 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+5,08% | 2.935 mld. | |
+1,41% | 79,66 mld. | |
+0,80% | 74,71 mld. | |
-17,06% | 52,02 mld. | |
+28,83% | 49,26 mld. | |
-27,36% | 44,97 mld. | |
+18,65% | 41,74 mld. | |
+54,79% | 36,02 mld. | |
-11,31% | 24,35 mld. |